

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Market Analysis and Insights: Global Targeted RNA Sequencing Market
Due to the COVID-19 pandemic, the global Targeted RNA Sequencing market size is estimated to be worth US$ 1800.6 million in 2022 and is forecast to a readjusted size of US$ 7570 million by 2029 with a CAGR of 22.5% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Exome Sequencing accounting for % of the Targeted RNA Sequencing global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Research Institutes segment is altered to an % CAGR throughout this forecast period.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
Global Targeted RNA Sequencing Scope and Market Size
The global Targeted RNA Sequencing market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Targeted RNA Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2029.
Segment by Type
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Segment by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted RNA Sequencing Market Size by Type (2018 VS 2022 VS 2029)
1.2.2 Exome Sequencing
1.2.3 Enrichment Sequencing
1.2.4 Amplicon Sequencing
1.3 Market by Application
1.3.1 Global Targeted RNA Sequencing Market Share by Application (2018 VS 2022 VS 2029)
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.3.4 Biotechnology Company
1.3.5 Diagnostic Lab
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Targeted RNA Sequencing Market Perspective (2018-2029)
2.2 Global Targeted RNA Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.3 Global Targeted RNA Sequencing Revenue Market Share by Region (2018-2023)
2.4 Global Targeted RNA Sequencing Revenue Forecast by Region (2024-2029)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Targeted RNA Sequencing Estimates and Projections (2018-2029)
2.5.2 Europe Targeted RNA Sequencing Estimates and Projections (2018-2029)
2.5.3 China Targeted RNA Sequencing Estimates and Projections (2018-2029)
2.5.4 Japan Targeted RNA Sequencing Estimates and Projections (2018-2029)
2.5.5 Southeast Asia Targeted RNA Sequencing Estimates and Projections (2018-2029)
2.5.6 India Targeted RNA Sequencing Estimates and Projections (2018-2029)
3 Global Targeted RNA Sequencing Competition Landscape by Players
3.1 Global Top Targeted RNA Sequencing Players by Revenue (2018-2023)
3.1.1 Global Top Targeted RNA Sequencing Players by Revenue (2018-2023)
3.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Targeted RNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Targeted RNA Sequencing Revenue
3.4 Global Targeted RNA Sequencing Market Concentration Ratio
3.4.1 Global Targeted RNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted RNA Sequencing Revenue in 2022
3.5 Targeted RNA Sequencing Key Players Head office and Area Served
3.6 Key Players Targeted RNA Sequencing Product Solution and Service
3.7 Date of Enter into Targeted RNA Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted RNA Sequencing Breakdown Data by Type
4.1 Global Targeted RNA Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Targeted RNA Sequencing Forecasted Market Size by Type (2024-2029)
5 Targeted RNA Sequencing Breakdown Data by Application
5.1 Global Targeted RNA Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Targeted RNA Sequencing Forecasted Market Size by Application (2024-2029)
6 United States Targeted RNA Sequencing Market Facts & Figures
6.1 United States Targeted RNA Sequencing Revenue by Company (2018-2023)
6.2 United States Targeted RNA Sequencing Market Size by Type
6.2.1 United States Targeted RNA Sequencing Market Size by Type (2018-2023)
6.2.2 United States Targeted RNA Sequencing Market Size by Type (2024-2029)
6.2.3 United States Targeted RNA Sequencing Market Share by Type (2018-2029)
6.3 United States Targeted RNA Sequencing Market Size by Application
6.3.1 United States Targeted RNA Sequencing Market Size by Application (2018-2023)
6.3.2 United States Targeted RNA Sequencing Market Size by Application (2024-2029)
6.3.3 United States Targeted RNA Sequencing Market Share by Application (2018-2029)
7 Europe Targeted RNA Sequencing Market Facts & Figures
7.1 Europe Targeted RNA Sequencing Revenue by Company (2018-2023)
7.2 Europe Targeted RNA Sequencing Market Size by Type
7.2.1 Europe Targeted RNA Sequencing Market Size by Type (2018-2023)
7.2.2 Europe Targeted RNA Sequencing Market Size by Type (2024-2029)
7.2.3 Europe Targeted RNA Sequencing Market Share by Type (2018-2029)
7.3 Europe Targeted RNA Sequencing Market Size by Application
7.3.1 Europe Targeted RNA Sequencing Market Size by Application (2018-2023)
7.3.2 Europe Targeted RNA Sequencing Market Size by Application (2024-2029)
7.3.3 Europe Targeted RNA Sequencing Market Share by Application (2018-2029)
8 China Targeted RNA Sequencing Market Facts & Figures
8.1 China Targeted RNA Sequencing Revenue by Company (2018-2023)
8.2 China Targeted RNA Sequencing Market Size by Type
8.2.1 China Targeted RNA Sequencing Market Size by Type (2018-2023)
8.2.2 China Targeted RNA Sequencing Market Size by Type (2024-2029)
8.2.3 China Targeted RNA Sequencing Market Share by Type (2018-2029)
8.3 China Targeted RNA Sequencing Market Size by Application
8.3.1 China Targeted RNA Sequencing Market Size by Application (2018-2023)
8.3.2 China Targeted RNA Sequencing Market Size by Application (2024-2029)
8.3.3 China Targeted RNA Sequencing Market Share by Application (2018-2029)
9 Japan Targeted RNA Sequencing Market Facts & Figures
9.1 Japan Targeted RNA Sequencing Revenue by Company (2018-2023)
9.2 Japan Targeted RNA Sequencing Market Size by Type
9.2.1 Japan Targeted RNA Sequencing Market Size by Type (2018-2023)
9.2.2 Japan Targeted RNA Sequencing Market Size by Type (2024-2029)
9.2.3 Japan Targeted RNA Sequencing Market Share by Type (2018-2029)
9.3 Japan Targeted RNA Sequencing Market Size by Application
9.3.1 Japan Targeted RNA Sequencing Market Size by Application (2018-2023)
9.3.2 Japan Targeted RNA Sequencing Market Size by Application (2024-2029)
9.3.3 Japan Targeted RNA Sequencing Market Share by Application (2018-2029)
10 Southeast Asia Targeted RNA Sequencing Market Facts & Figures
10.1 Southeast Asia Targeted RNA Sequencing Revenue by Company (2018-2023)
10.2 Southeast Asia Targeted RNA Sequencing Market Size by Type
10.2.1 Southeast Asia Targeted RNA Sequencing Market Size by Type (2018-2023)
10.2.2 Southeast Asia Targeted RNA Sequencing Market Size by Type (2024-2029)
10.2.3 Southeast Asia Targeted RNA Sequencing Market Share by Type (2018-2029)
10.3 Southeast Asia Targeted RNA Sequencing Market Size by Application
10.3.1 Southeast Asia Targeted RNA Sequencing Market Size by Application (2018-2023)
10.3.2 Southeast Asia Targeted RNA Sequencing Market Size by Application (2024-2029)
10.3.3 Southeast Asia Targeted RNA Sequencing Market Share by Application (2018-2029)
11 India Targeted RNA Sequencing Market Facts & Figures
11.1 India Targeted RNA Sequencing Revenue by Company (2018-2023)
11.2 India Targeted RNA Sequencing Market Size by Type
11.2.1 India Targeted RNA Sequencing Market Size by Type (2018-2023)
11.2.2 India Targeted RNA Sequencing Market Size by Type (2024-2029)
11.2.3 India Targeted RNA Sequencing Market Share by Type (2018-2029)
11.3 India Targeted RNA Sequencing Market Size by Application
11.3.1 India Targeted RNA Sequencing Market Size by Application (2018-2023)
11.3.2 India Targeted RNA Sequencing Market Size by Application (2024-2029)
11.3.3 India Targeted RNA Sequencing Market Share by Application (2018-2029)
12 Key Players Profiles
12.1 Thermo Fisher
12.1.1 Thermo Fisher Company Details
12.1.2 Thermo Fisher Business Overview
12.1.3 Thermo Fisher Targeted RNA Sequencing Introduction
12.1.4 Thermo Fisher Revenue in Targeted RNA Sequencing Business (2018-2023)
12.1.5 Thermo Fisher Recent Development
12.2 Illumina
12.2.1 Illumina Company Details
12.2.2 Illumina Business Overview
12.2.3 Illumina Targeted RNA Sequencing Introduction
12.2.4 Illumina Revenue in Targeted RNA Sequencing Business (2018-2023)
12.2.5 Illumina Recent Development
12.3 Roche Holdings
12.3.1 Roche Holdings Company Details
12.3.2 Roche Holdings Business Overview
12.3.3 Roche Holdings Targeted RNA Sequencing Introduction
12.3.4 Roche Holdings Revenue in Targeted RNA Sequencing Business (2018-2023)
12.3.5 Roche Holdings Recent Development
12.4 BGI
12.4.1 BGI Company Details
12.4.2 BGI Business Overview
12.4.3 BGI Targeted RNA Sequencing Introduction
12.4.4 BGI Revenue in Targeted RNA Sequencing Business (2018-2023)
12.4.5 BGI Recent Development
12.5 Eurofins
12.5.1 Eurofins Company Details
12.5.2 Eurofins Business Overview
12.5.3 Eurofins Targeted RNA Sequencing Introduction
12.5.4 Eurofins Revenue in Targeted RNA Sequencing Business (2018-2023)
12.5.5 Eurofins Recent Development
12.6 LabCorp
12.6.1 LabCorp Company Details
12.6.2 LabCorp Business Overview
12.6.3 LabCorp Targeted RNA Sequencing Introduction
12.6.4 LabCorp Revenue in Targeted RNA Sequencing Business (2018-2023)
12.6.5 LabCorp Recent Development
12.7 Berry Genomics
12.7.1 Berry Genomics Company Details
12.7.2 Berry Genomics Business Overview
12.7.3 Berry Genomics Targeted RNA Sequencing Introduction
12.7.4 Berry Genomics Revenue in Targeted RNA Sequencing Business (2018-2023)
12.7.5 Berry Genomics Recent Development
12.8 Macrogen
12.8.1 Macrogen Company Details
12.8.2 Macrogen Business Overview
12.8.3 Macrogen Targeted RNA Sequencing Introduction
12.8.4 Macrogen Revenue in Targeted RNA Sequencing Business (2018-2023)
12.8.5 Macrogen Recent Development
12.9 GENEWIZ
12.9.1 GENEWIZ Company Details
12.9.2 GENEWIZ Business Overview
12.9.3 GENEWIZ Targeted RNA Sequencing Introduction
12.9.4 GENEWIZ Revenue in Targeted RNA Sequencing Business (2018-2023)
12.9.5 GENEWIZ Recent Development
13 Market Dynamics
13.1 Targeted RNA Sequencing Industry Trends
13.2 Targeted RNA Sequencing Market Drivers
13.3 Targeted RNA Sequencing Market Challenges
13.4 Targeted RNA Sequencing Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Ìý
Ìý
*If Applicable.